Aprotinin is not associated with postoperative renal impairment after primary coronary surgery.
about
Aprotinin may increase mortality in low and intermediate risk but not in high risk cardiac surgical patients compared to tranexamic acid and ε-aminocaproic acid -- a meta-analysis of randomised and observational trials of over 30.000 patientsContinuous localized monitoring of plasmin activity identifies differential and regional effects of the serine protease inhibitor aprotinin: relevance to antifibrinolytic therapyEarly postoperative outcomes and blood product utilization in adult cardiac surgery: the post-aprotinin era.Natural and engineered plasmin inhibitors: applications and design strategies.
P2860
Aprotinin is not associated with postoperative renal impairment after primary coronary surgery.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Aprotinin is not associated wi ...... fter primary coronary surgery.
@en
Aprotinin is not associated wi ...... fter primary coronary surgery.
@nl
type
label
Aprotinin is not associated wi ...... fter primary coronary surgery.
@en
Aprotinin is not associated wi ...... fter primary coronary surgery.
@nl
prefLabel
Aprotinin is not associated wi ...... fter primary coronary surgery.
@en
Aprotinin is not associated wi ...... fter primary coronary surgery.
@nl
P2093
P1476
Aprotinin is not associated wi ...... fter primary coronary surgery.
@en
P2093
Gabriella Lindvall
Jan van der Linden
Torbjörn Ivert
P356
10.1016/J.ATHORACSUR.2008.03.033
P407
P577
2008-07-01T00:00:00Z